Sigilon Therapeutics Investors
Sigilon Therapeutics is a venture capital fund based in Cambridge, Massachusetts, established in 2015 The firm specializes in investing in innovative biotechnology companies that focus on transformative therapies With a significant investment scale of $126 million, Sigilon Therapeutics aims to support the development of groundbreaking solutions in the healthcare sector The fund is committed to advancing scientific research and fostering the growth of its portfolio companies Through strategic investments, Sigilon Therapeutics seeks to enhance patient outcomes and drive progress in the life sciences industry
Founded Date:
2015
Last Funding Type:
Post-IPO Equity
Headquarters:
USA
Investors Number:
5
Employee Number:
51-100
Industry:
FemTech
Estimated Revenue:
$10M to $50M
Last Funding Date:
2020
Investor Type:
Venture Capital Funds
Total Funding:
263200000